Patents by Inventor Jérémy Duboeuf

Jérémy Duboeuf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS
    Publication number: 20220275056
    Abstract: A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 1, 2022
    Inventors: Ian Cottingham, Daniel Plaksin, Jérémy Duboeuf
  • Selective IL-6-trans-signalling inhibitor compositions
    Patent number: 11306136
    Abstract: A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: April 19, 2022
    Assignee: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Jérémy Duboeuf
  • SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS
    Publication number: 20200123226
    Abstract: A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses.
    Type: Application
    Filed: November 6, 2019
    Publication date: April 23, 2020
    Inventors: Ian Cottingham, Daniel Plaksin, Jérémy Duboeuf
  • Selective IL-6-trans-signalling inhibitor compositions
    Patent number: 10519218
    Abstract: A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: December 31, 2019
    Assignee: FERRING B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Jérémy Duboeuf
  • SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS
    Publication number: 20180282396
    Abstract: A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses.
    Type: Application
    Filed: December 1, 2015
    Publication date: October 4, 2018
    Applicant: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Jérémy Duboeuf